# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Charles Darwin (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI003-SYN
- Date: 2026-07-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Bernard Ashworth, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine visit, established patient, 40 to 64 years)

## Chief complaint

Preventive health visit; no new complaints. **S**

## History of present illness

Mr. Darwin is a 40-year-old man with a provisional diagnosis of cyclic vomiting syndrome who comes for his preventive health visit, six weeks after his three-month review. He has had no vomiting episode since then and no emergency visits this year since starting treatment. He takes amitriptyline 75 mg at bedtime with a dry mouth and mild constipation, and carries his sumatriptan and ondansetron. His cold in May cleared in two weeks without an episode. He walks most days and practices relaxation breathing each evening. He completed the health risk assessment in the waiting room. **S**

| Element | Detail |
|---|---|
| Visit | Periodic preventive visit, age 40 |
| Active conditions | Cyclic vomiting syndrome, provisional, on amitriptyline prophylaxis |
| Medicines | Amitriptyline 75 mg at bedtime; sumatriptan nasal spray and ondansetron dissolving tablets for episodes |
| Safety events | No emergency visits or hospital stays since treatment began |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Better than in the winter, in his words |
| Psychosocial | Lives with his family; works from home; less worried about episodes in company since treatment began |
| Tobacco and nicotine | Does not smoke or vape |
| Alcohol | One or two glasses of wine a week (AUDIT-C 2) |
| Cannabis and other drugs | None |
| Physical activity | Walks 30 to 45 minutes most days |
| Nutrition | Regular small meals, as advised for his trigger plan |
| Sleep | Seven to eight hours; mild morning grogginess on amitriptyline |
| Home and road safety | Wears a seat belt; smoke detectors working; no firearms in the home |
| Sexual health | One long-term partner; no new partners |
| Hearing and vision | No concerns |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight up 1 kg since treatment began; no fever or night sweats |
| Eyes | Negative | No blurred vision |
| Ears, nose, mouth, and throat | Positive | Dry mouth on amitriptyline; cold resolved |
| Cardiovascular | Negative | No chest pain or fainting; palpitations only in past prodromes |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Positive | Mild constipation on amitriptyline; wind between episodes less troublesome; no vomiting since the three-month review |
| Genitourinary | Negative | No hesitancy or urinary symptoms |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No rash or changing moles |
| Neurological | Negative | No headaches or dizziness |
| Psychiatric | Negative | Mood good; PHQ-2 score 0; no thoughts of self-harm |
| Endocrine | Negative | No heat or cold intolerance |

12 systems reviewed. **S**

## Current medications

- Amitriptyline 75 mg oral tablet, one tablet at bedtime **S**
- Sumatriptan 20 mg nasal spray, one spray at the first sign of an episode **S**
- Ondansetron 8 mg orally disintegrating tablet at the first sign of an episode **S**

## Allergies

- No known allergy **S**

## Objective

BP 116/72 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 72.6 kg; BMI 21.7 kg/m². All vital signs are synthetic.

PHQ-2: 0; AUDIT-C: 2; Total cholesterol: 178 mg/dL; HDL cholesterol: 58 mg/dL; LDL cholesterol: 102 mg/dL; Triglycerides: 90 mg/dL. All results are synthetic.

## Immunizations given today

- Hepatitis B vaccine (adjuvanted, two-dose series), dose 1 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well and relaxed; weight 72.6 kg, BMI 21.7 |
| Eyes | Pupils equal and reactive; visual acuity 20/20 both eyes |
| Ears, nose, and throat | Canals and drums normal; oral mucosa slightly dry; dentition good |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm at 70 per minute; no murmur; blood pressure 116/72 mmHg |
| Respiratory | Clear to auscultation bilaterally |
| Abdomen | Soft and non-tender; no masses or organ enlargement |
| Musculoskeletal | Full range of motion; normal gait |
| Skin | No suspicious lesions |
| Neurological | Alert and oriented; no focal deficit |
| Psychiatric | Calm and engaged |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Preventive visit, age 40**. Health risk assessment reviewed and a written prevention plan given. Depression and alcohol screens negative. Ten-year cardiovascular risk is below 5 percent by the pooled cohort equations, so no statin is indicated. **S**
   - Next preventive visit in one year.
2. **Cyclic vomiting syndrome, provisional** (R11.15). No episode in six weeks on amitriptyline 75 mg. Dry mouth and mild constipation are tolerable. **S**
   - Continue amitriptyline 75 mg at bedtime.
   - More fluid and fiber for the constipation.
   - Six-month review in about seven weeks.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Depression screening | Completed today | PHQ-2 score 0; PHQ-9 also followed every three months on amitriptyline |
| Anxiety screening | Up to date | GAD-7 6 six weeks ago, down from 8; repeated every three months |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 2; within low-risk limits |
| Unhealthy drug use screening | Completed today | No cannabis or other drug use |
| Tobacco use | Completed today | Does not smoke or vape |
| Blood pressure screening | Completed today | 116/72 mmHg; recheck yearly from 40 |
| Cholesterol screening and statin decision | Completed today | Total cholesterol 178, HDL 58, LDL 102, triglycerides 90 mg/dL; ten-year risk below 5 percent; no statin indicated |
| Diabetes screening | Not indicated | Recommended for adults 35 to 70 with overweight or obesity; BMI 21.7, and glucose was normal in March |
| HIV screening | Ordered | One-time antigen and antibody test, with his consent; no prior result on record |
| Hepatitis C screening | Ordered | One-time antibody test with reflex RNA, with his consent |
| Hepatitis B screening | Ordered | One-time triple panel (surface antigen, surface antibody, and core antibody), drawn before today's vaccine dose |
| Hepatitis B vaccine | Completed today | No record of a prior series; first dose of the two-dose adjuvanted vaccine given today, second dose in one month |
| Influenza vaccine | Due | This season's vaccine due in the autumn |
| COVID-19 vaccine | Due | Discussed; he plans to have this season's vaccine with the influenza vaccine |
| Tdap | Up to date | Booster about seven years ago; next due in about three years |
| HPV vaccine | Not indicated | Routine catch-up ends at 26; at 40 with no new risk, not recommended after discussion |
| Colorectal cancer screening | Not indicated | Starts at 45 |
| Prostate cancer screening | Not indicated | Shared decision starts at 55 |
| Advance care planning | Completed today | Discussed; he will choose a health care agent and return the form |

## Advance care planning

Advance care planning was introduced as part of routine preventive care. He has no advance directive. He would like the person he lives with to speak for him if he could not, and took home the health care agent form; the agent is not named in this record. He said that what matters most is being able to keep working and to be told plainly what is known and what is not. No treatment decisions were made. **S**

## Guideline basis

- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Six-month review of the cyclic vomiting plan in about seven weeks. Second hepatitis B dose in one month. HIV, hepatitis C, and hepatitis B results by portal message. Next preventive visit in one year. **S**
- Next scheduled visit 2026-09-08: six-month review of response to prophylaxis. **S**
